Table 1 Summary of the dogs, and data on transplanted cells.
From: In vivo stem cell tracking using scintigraphy in a canine model of DMD
Name of the dog | Status | Sex | Age (months) | Cell type | Labelling efficiency | Cell Viability |
|---|---|---|---|---|---|---|
Bigoune | WT | F | 17.2 | 111In-oxine | — | — |
Aorte | WT | F | 29.1 | 111In-labelled leukocytes | 63% | 96% |
B’carre | WT | F | 6.8 | 111In-labelled MABs | 88% | 30% |
T’artine | WT | F | 59.8 | 111In-labelled MABs | 81% | 96% |
Btrave | WT | F | 19.6 | 111In-labelled MABs | 64% | 72% |
Cto | GRMD | M | 3.8 | 111In-labelled MABs | 70% | 77% |
Eole | GRMD | M | 4.6 | 111In-labelled MABs | 54% | 42% |
Extra | GRMD | M | 4.3 | 111In-labelled MABs | 63% | 35% |
Enzyme | GRMD | F | 5.1 | 111In-labelled MABs | 59% | 93% |
Enigme | GRMD | F | 4.9 | 111In-labelled MABs | 65% | 93% |
Ifi | GRMD | F | 4.7 | 111In-labelled myoblasts | 49% | 80% |
Itineris | GRMD | F | 4.0 | 111In-labelled myoblasts | 55% | 53% |
